SCHEMBL1851691

SCHEMBL1851691

CC(Nc1ncc(C(N)=O)c(Nc2cccc(C#N)c2)n1)C(C)C(N)=O

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SYK P43405 20/20 0.79
ZAP70 P43403 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2627354 0.89 SYK (1.00) SYKZAP70
SCHEMBL1849682 0.85 SYK (0.78) SYK
SCHEMBL1852542 0.83 SYK (0.82) SYK
SCHEMBL1853030 0.83 SYK (0.82) SYK
SCHEMBL1353409 0.82 SYK (0.69) SYKZAP70
SCHEMBL1847518 0.82 SYK (0.80) SYK
SCHEMBL1848955 0.80 SYK (0.72) SYK
SCHEMBL2627207 0.80 SYK (0.67) SYKZAP70
SCHEMBL1845986 0.78 SYK (0.82) SYK
SCHEMBL1849385 0.77 SYK (0.80) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323993-A2 2,6-DIAMINO- PYRIMIDIN- 5-YL-CARBOXAMIDES AS SYK OR JAK KINASES INHIBITORS Portola Pharmaceuticals, Inc. (US) 2011-05-25 EP disclosed
WO-2009136995-A2 INHIBITORS OF SYK PROTEIN KINASE PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-12 WO disclosed